Clinical trial · Interventional
RJBC-APP and Breast Cancer Treatment Compliance
Mobile Medical Application on Adjuvant Therapy Compliance and Quality of Life in Patients With Early Breast Cancer: a Multicentric, Open-labeled, Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this multicentric randomized controlled clinical trial is to test the role of mobile medical application (APP) on adjuvant therapy compliance and quality of life (QoL) in patients with early breast cancer. Participants assigned to the Ruijin Breast Cancer APP (RJBC-APP) group can receive treatment reminders, matters needing attention as well as science knowledge and they can communicate with the medical staff during adjuvant treatments while follow-up can only be conducted in outpatient clinic for those in the Control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Routine post-surgical follow-up | Other | — | UNRESOLVED |
| The RJBC-APP | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- The RJBC-APP group
- description
- Participants randomized to the RJBC-APP group should register on the RJBC-APP, through which they can receive treatment reminders, matters needing attention as well as science knowledge and communicate with the medical staff.
- interventionNames
- Device: The RJBC-APP
- Other: Routine post-surgical follow-up
- type
- ACTIVE_COMPARATOR
- label
- The Control group
- description
- Participants randomized to the Control group have no access to the RJBC-APP and post-surgical follow-up can only be conducted in outpatient clinic.
- interventionNames
- Other: Routine post-surgical follow-up
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: 1. Females aged 18-70 2. Eastern Cooperative Oncology Group Performance Status Score 0-2 3. Breast cancer by pathology 4. Adjuvant therapy by multidisciplinary team 5. Written informed consent form Exclusion Criteria: 1. Distant metastases at diagnosis 2. Unable to use a smartphone
References
Publications (1)
- DERIVEDZhu S, Li S, Qu R, Ren W, Hu C, Chen X. Association of mobile application information on multidisciplinary therapy and treatment compliance in early-stage breast cancer: A prospective multicenter randomized phase III study. Breast. 2026 Aug;88:104811. doi: 10.1016/j.breast.2026.104811. Epub 2026 May 14. PMID 42150214